Jasper Therapeutics has completed its acquisition of Kira Pharmaceuticals, creating a combined clinical-stage immunology company with three major development programs and access to resources in both the United States and China, while a concurrent $132 million financing is expected to fund planned operations through the second half of 2028.
Canton Strategic Holdings could increase its active Super Validator weight as much as 30-fold through the first quarter of 2028 as the company scales its role within the Canton Network and begins generating meaningful operating revenue from a new Canton Coin locking service.
Lantern Pharma says its artificial intelligence-driven drug development model has enabled the company to advance new oncology programs from initial AI-derived insights to first-in-human clinical trials for approximately $2 million to $3 million per program, substantially below what management describes as typical industry development costs.
LanzaTech reduced second-quarter operating expenses by 67% year over year as an extensive cost-reduction and organizational restructuring program helped the carbon management company narrow its adjusted EBITDA loss by about 74%.
Rein Therapeutics has surpassed 25% enrollment in its global Phase 2 RENEW trial of LTI-03 for idiopathic pulmonary fibrosis, with enrollment running ahead of schedule and interim clinical data still expected during the second half of 2026 as the company simultaneously reduces R&D and administrative spending.
StablecoinX's cross-chain infrastructure has surpassed $3 billion in cumulative verified volume as the newly public stablecoin infrastructure company builds operating businesses around an ENA treasury representing approximately 20% of the token’s total supply.
Teamshares' trailing-12-month pro forma revenue reached approximately $560 million at the end of the second quarter of 2026 as the newly public company continues building a diversified portfolio of small and midsized businesses through its programmatic acquisition strategy.
Sigma Lithium plans to increase installed lithium oxide concentrate capacity to approximately 830,000 tons annually by the end of 2028, as record second-quarter profitability, lower production costs, and improving operating productivity support a multi-stage expansion of its Brazilian operations.
Suncrete maintained its fiscal 2026 revenue outlook of $420 million to $480 million as strong construction demand across the U.S. Sunbelt and contributions from recent acquisitions helped offset unusually wet weather during the second quarter.
Replimune completed a $150 million financing as the biotechnology company prepares to commercially launch TUDRIQEV following FDA accelerated approval and continues the Phase 3 confirmatory trial required to support the treatment’s longer-term regulatory position.
Americas Gold and Silver plans approximately $45 million to $60 million of combined growth and exploration capital during 2026 as the company increases production capacity at its Galena Complex and conducts what management describes as the largest drilling campaign in its history.
Sinda says its existing mineral resources and conceptual exploration targets provide visibility to more than 800 million silver-equivalent ounces at its project in Mexico, even though drilling has covered only approximately 38% of known veins.
RLX Technology's gross profit rose 47.8% year over year in the second quarter of 2026 as a more favorable revenue mix and supply-chain optimization helped the global e-vapor company expand gross margin by 790 basis points.
Super League's weighted sales pipeline per seller for opportunities through the end of 2026 increased approximately 57% to $2.8 million as the audience intelligence and media activation company expands its commercial organization and integrates new advertising capabilities.
Data Storage Corporation's Nexxis business increased Q2 gross profit by about 22% year over year as revenue from continuing operations rose 9.3%, giving the company a recurring-revenue operating base as it pursues a broader technology acquisition strategy.
VerifyMe's gross margin rose 1,900 basis points to 54% in the second quarter of 2026, even as revenue fell 58%, reflecting shifting economics in the company’s logistics business as it transitions customers to a new strategic shipping partner and expands higher-value Premium services.
Upland Software generated $5.3 million of free cash flow during the second quarter of 2026, nearly double the $2.7 million generated a year earlier, even as reported revenue declined following a series of business divestitures completed in 2025.
Allarity Therapeutics completed its Phase 3-ready manufacturing campaign for stenoparib ahead of schedule and says it does not currently anticipate additional cash outlays for active pharmaceutical ingredient manufacturing as the company prepares the cancer therapy for potential pivotal development.
Linklaters is continuing to expand its U.S. litigation and sports practices by adding César Rivière as a partner in New York, alongside Counsel Grant May and Associate Cara Day. All three lawyers join from Paul Weiss.
iFoodDS is increasing its investment in Trace Exchange, its connected food traceability platform, as part of a strategic refocusing that includes the sale of its Quality Insights business to Foods Connected. Financial terms of the transaction were not disclosed.
Norton Rose Fulbright has appointed Kate Jefferson as a corporate partner in Sydney, strengthening its Asia-Pacific transactional practice with a lawyer who has more than 20 years of experience advising on complex cross-border M&A and capital markets transactions. Jefferson joins Norton Rose Fulbright from Baker McKenzie.
Dentons Link Legal has appointed Arjun Nihal Singh as a partner in its Competition Law Practice Group, adding an experienced antitrust lawyer as the firm expands its capabilities across competition law, merger control, and regulatory matters.
SWI Group has announced a strategic partnership with Brookfield Asset Management involving 13 properties from Varia US Properties’ U.S. multifamily portfolio through a newly created two-vehicle joint venture with an aggregate gross asset value of approximately $693.9 million.
Linklaters has appointed Alun Evans as a partner in its corporate practice in Singapore, bringing the veteran M&A lawyer back to the firm as it continues investing in high-end transactional capabilities across Asia. Evans is expected to rejoin Linklaters in August.
White & Case has appointed Tarun Warriar as a partner in Hong Kong, expanding its Global Financial Restructuring and Insolvency Practice and Global Private Capital Industry Group amid increasing demand for complex restructuring and special situations advice across Asia-Pacific.
Astara Capital Partners has acquired Dynatec Systems, adding a nearly five-decade-old industrial wastewater treatment business to its middle-market portfolio as demand increases for water reuse, treatment infrastructure and solutions for difficult industrial waste streams. Financial terms of the transaction were not disclosed.
SWI Group has accelerated a major strategic shift toward digital infrastructure, with more than 80% of its capital now allocated to a transatlantic portfolio exceeding 4 GW of power capacity and plans to push that allocation above 90% over time.
PTC Therapeutics has been selected as the winning bidder to acquire Sangamo Therapeutics’ ST-920 Fabry disease gene therapy program in a bankruptcy auction for $111 million upfront and up to $100 million in additional regulatory milestone payments. The acquisition could have a total value of up to $211 million.
The Virginia Retirement System generated a 12.1% investment return, net of fees, during fiscal 2026, increasing the market value of its retirement trust fund to $135.2 billion as of June 30.
Pulse 2.0 NewsletterDaily business and finance intelligence.
Subscribe to the Pulse 2.0 Newsletter
Stay informed with the day's intelligence on business, finance, capital markets, deal flow, law, tech, and AI delivered to your inbox each evening at 6pm ET.